![Mark Eisner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Eisner
Direktör/Styrelseledamot på
ZURA BIO LIMITED
Förmögenhet: 110 623 $ per 2026-07-31
Profil
Mark D.
Eisner is currently Director at The Genentech Foundation, Independent Director at Zura Bio Ltd. starting in 2026, and Director at Jade Biosciences, Inc. starting in 2026.
Former positions include SVP & Global Head-Product Development Immunology at Genentech, Inc., Chief Medical Officer & Executive Vice President at Kyntra Bio, Inc. from 2020 to 2023, Professor at The University of California, San Francisco, Chief Medical Officer at Sonoma Biotherapeutics, Inc. from 2023 to 2024, and Chief Medical Officer & Executive Vice President at Vir Biotechnology, Inc. from 2024 to 2026.
Education includes undergraduate studies at Stanford University, and doctorates from UC Berkeley School of Public Health and the University of Pennsylvania Medical Center.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
VIR BIOTECHNOLOGY, INC. 0,01 % | 2026-03-31 | 12 774 ( 0,01 % ) | 110 623 $ | 2026-07-31 |
| 2026-06-25 | 0 ( -.--% ) | - $ | 2026-07-31 | |
| 2026-06-17 | 0 ( -.--% ) | - $ | 2026-07-31 |
Aktiva positioner av Mark Eisner
| Företag | Position | Start |
|---|---|---|
| ZURA BIO LIMITED | Direktör/Styrelseledamot | 2026-02-21 |
| JADE BIOSCIENCES, INC. | Direktör/Styrelseledamot | 2026-06-25 |
The Genentech Foundation
 The Genentech Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Mark Eisner
| Företag | Position | Slut |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2026-04-24 |
Sonoma Biotherapeutics, Inc.
 Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in research, development and manufacturing cell and genetic therapy for autoimmune and degenerative diseases | Teknisk/Vetenskaplig/F&U Direktör | 2024-06-01 |
| KYNTRA BIO, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2023-09-08 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Företagsledare/Principal | - |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
Mark Eisners utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
59
Första gradens relationer
11
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 11 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FibroGen, Inc.
 FibroGen, Inc. Pharmaceuticals: MajorHealth Technology Develops biotechnology-based drugs | Health Technology |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Genentech Foundation
The Genentech Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
UC Berkeley School of Public Health
 UC Berkeley School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania Medical Center
 University of Pennsylvania Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vir Biotechnology, Inc.
 Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
Aerovate Therapeutics, Inc.
 Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Sonoma Biotherapeutics, Inc.
Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in research, development and manufacturing cell and genetic therapy for autoimmune and degenerative diseases | Health Technology |
Zura Bio Ltd.
 Zura Bio Ltd. BiotechnologyHealth Technology Operates as a multi-asset clinical-stage biotechnology company that focuses on develops novel medicines for immune and inflammatory disorders | Health Technology |
